Kala Bio Inc Reports Results For The Quarter Ended In June: Earnings Summary

KALA BIO

09/08/2023 14:32

* KALA BIO Inc  KALA.OQ  reported a quarterly adjusted loss
of
$4.36​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss of
$3.19 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * KALA BIO Inc's reported EPS for the quarter was a loss of
$4.36​.
    * The mean earnings estimate of analysts had risen by
about 28.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * KALA BIO Inc shares had fallen by 8.5% this quarter and
lost 65.0% so far this year.
    * The company reported a quarterly loss of $10.41 million.
    * Wall Street's median 12-month price target for KALA BIO
Inc is
$27.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -3.19          -4.36          Missed
 Mar. 31 2023      -4.43          -6.99          Missed
 Dec. 31 2022      -6.92          -7.97          Missed
 Sep. 30 2022      16.83          19.25          Beat